Pediatric model‐based dose optimization using a pooled exposure–response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma
- Resource Type
- article
- Authors
- Shengnan Du; Yue Zhao; Zheyi Hu; Sihang Liu; Amit Roy; Jun Shen; Li Zhu; Lora Hamuro
- Source
- CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 1, Pp 168-179 (2024)
- Subject
- Therapeutics. Pharmacology
RM1-950
- Language
- English
- ISSN
- 2163-8306
Abstract An exposure–response (E–R) safety analysis was conducted across adult and pediatric (